Viruses-Basel

Papers
(The H4-Index of Viruses-Basel is 68. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution506
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention403
A Roadmap for Genome-Based Phage Taxonomy328
VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses287
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms279
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design239
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation220
Comparison of Rapid Antigen Tests for COVID-19173
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice170
Herpes zoster: A Review of Clinical Manifestations and Management158
Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance151
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?149
Mutations and Evolution of the SARS-CoV-2 Spike Protein148
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection138
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies133
Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy132
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease132
The Advantages and Challenges of Using Endolysins in a Clinical Setting131
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)130
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production128
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19126
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro123
Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses118
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-115
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA114
Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature105
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications105
The Mechanism behind Influenza Virus Cytokine Storm104
African Swine Fever in Wild Boar in Europe—A Review101
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner101
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues100
Neutralizing Antibody Therapeutics for COVID-1999
The Spike of Concern—The Novel Variants of SARS-CoV-296
Lentiviral Vector Bioprocessing96
Persistent Human Papillomavirus Infection91
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies90
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives87
Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation87
SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations85
Antiviral Activity Exerted by Natural Products against Human Viruses85
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals83
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics80
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light80
Recombination in Coronaviruses, with a Focus on SARS-CoV-280
Current Developments and Challenges in Plant Viral Diagnostics: A Systematic Review78
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development78
Clinical Update of Severe Fever with Thrombocytopenia Syndrome78
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b277
Monkeypox: A Comprehensive Review76
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML18875
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein74
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations72
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient72
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse71
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week71
Viral Vectors for COVID-19 Vaccine Development71
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review70
ASFV-G-∆I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever70
An Update of Orthopoxvirus Molecular Evolution69
ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data69
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion69
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India68
World-Wide Prevalence and Genotype Distribution of Enteroviruses68
Current Trend in Antiviral Therapy for Chronic Hepatitis B68
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-268
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment68
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-268
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence68
0.058572053909302